Solitary Solid Tumors
📧 Sign up to get email alerts when something new happens for Solitary Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors [Phase 2]
Phase II study of ilorasertib (ABT-348) in CDKN2A-deficient solid tumors was terminated; results posted.